Legislative, Regulatory & Legal

Dr. Britney Grayson had just finished regaling children at the small religious grade school about Kenya, where she works on missions, when she drove out of the parking lot looking for a Starbucks.

National Drug Scheduling Advisory Committee issues interim recommendations on drug schedule status change for loratadine products used in children two to 11 years of age. 

Adrian Dix said in January that the government would be investigating why almost 10% of prescriptions for the drug in B.C. were filled for American citizens.

The decision to discontinue providing obstetrical services was emotional and difficult, hospital officials said in a news release.

The city’s submission, an update to its initial January 2022 request, indicates Toronto wants the federal agency to go further than the exemption it recently granted to British Columbia under the Controlled Drugs and Substances Act.

The action comes as a federal judge in Texas is considering a lawsuit that would overturn decades-old federal approval of the drug.

The Toronto-based company which operates four psychedelic therapy clinics says the Ontario Superior Court of Justice granted it a creditor protection order today under the Companies’ Creditors Arrangement Act.

Optometrists withdrew from performing provincially insured eye services from September to November 2021 amid a dispute over the amount they were being reimbursed.